Table 3.
Reported cases of Myroides spp. strains isolated from the urine, as found in the USA National Library of Medicine (PubMed) database (May 12, 2017)
| Case no. | Gender/age (years) | Clinical condition/indwelling device | Antibiotic resistance status | Treatment for Myroides UTIs | Outcome | Report/year/reference |
|---|---|---|---|---|---|---|
| 1 | M/66 | Bilateral hydronephrosis, bilateral ureteric stones/left DJ stent | Resistant to all beta- lactam and non-beta- lactam antibiotics, including imipenem, vancomycin, ciprofloxacin, chloramphenicol | Imipenem, colistin | Failure | Ktari et al/2012/19 |
| 2 | M/44 | Bilateral hydronephrosis, bilateral ureteric stones, left kidney stone/bilateral DJ stent | No treatment (bladder colonization) | Favorable | Ktari et al/2012/19 | |
| 3 | M/44 | Left ureteric stone/left DJ stent | No treatment (bladder colonization) | Favorable | Ktari et al/2012/19 | |
| 4 | M/47 | BPH, bladder calculi | No treatment (bladder colonization) | Favorable | Ktari et al/2012/19 | |
| 5 | M/77 | Right hydronephrosis, right ureteric stone/right DJ stent | Rifampicin + ciprofloxacin | Cured | Ktari et al/2012/19 | |
| 6 | M/65 | BPH, bladder calculi, prostatitis | Rifampicin + ciprofloxacin | Cured | Ktari et al/2012/19 | |
| 7 | M/80 | Bladder cancer | Rifampicin + ciprofloxacin | Cured | Ktari et al/2012/19 | |
| 42 | M/38 | Relapsing UTIs, bladder carcinoma | ND | ND | Holmes et al/1979/27 | |
| 8–11 (four cases) | ND/ND | Neoplasia of the urinary tract/catheterization Urinary calculi/catheterization ND | Resistant to all 12 antimicrobial agents tested (amikacin, aztreonam, cefoperazone, ceftazidime, ceftriaxone, ciprofloxacin, gentamicin, imipenem, piperacillin, tetracycline, tobramycin, trimethoprim–sulfamethoxazole) | ND | ND | Yağci et al/2000/20 |
| ND | ND | Yağci et al/2000/20 | ||||
| ND | ND | Yağci et al/2000/20 | ||||
| ND | ND | Yağci et al/2000/20 | ||||
| 12–20 (nine cases) | ND/ND | 12–20 (nine cases) | ND | ND | Yağci et al/2000/20 | |
| 21–29 (nine cases) | ND/ND | 21–29 (nine cases) | ND | ND | Yağci et al/2000/20 | |
| 30 | F/48 | Cystitis (contaminant) | Fully resistant to clinically obtainable levels of streptomycin, kanamycin, gentamicin, tobramycin, amikacin, ampicillin, carbenicillin, chloramphenicol, tetracycline, polymyxin B, and erythromycin Resistant or moderately sensitive to sulfamethoxazole, cotrimoxazole, cephaloridine and nalidixic acid | Furadantin | ND | Holmes et al/1979/27 |
| 31 | F/59 | ND (contaminant) | ND | ND | Holmes et al/1979/27 | |
| 32 | F/ND | Urinary retention (not clinically significant) | ND | ND | Holmes et al/1979/27 | |
| 33 | ND/ND | Not known | ND | ND | Holmes et al/1979/27 | |
| 34 | F/67 | Total cystectomy, ileal loop urethrotomy (mixed culture) | ND | ND | Holmes et al/1979/27 | |
| 35 | M/48 | Renal insufficiency, pyelonephritis, renal calculi (mixed culture) | ND | ND | Holmes et al/1979/27 | |
| 36 | M/54 | ND (very scanty numbers) | ND | ND | Holmes et al/1979/27 | |
| 37 | M/87 | ND (mixed culture) | ND | ND | Holmes et al/1979/27 | |
| 38 | M/46 | ND (Mixed culture) | ND | ND | Holmes et al/1979/27 | |
| 39 | M/59 | ND (mixed culture) | ND | ND | Holmes et al/1979/27 | |
| 40 | F/ND | ND (mixed culture) | ND | ND | Holmes et al/1979/27 | |
| 41 | M/67 | Multideficiency syndrome, pyelonephritis, liver disease (mixed culture) | ND | ND | Holmes et al/1979/27 | |
| 43 | ND/ND | ND | ND | ND | Holmes et al/1979/27 | |
| 44 | M/ND | Syringomyelia/indwelling catheter | ND | ND | Holmes et al/1979/27 | |
| 45 | F/ND | Relapsing urinary infection, renal insufficiency, hypertension | ND | ND | Holmes et al/1979/27 | |
| 46 | M/19 | Spina bifida/permanent catheter | ND | ND | Holmes et al/1979/27 | |
| 47 | ND/ND | ND | ND | ND | Holmes et al/1979/27 |
Abbreviations: BPH, benign prostatic hyperplasia; DJ, double-J; ND, not described; UTI, urinary tract infection.